Contribution: Industrial Research Assistance Program – Contributions to Firms
Immunity Diagnostics Inc
$35,200.00
Development and validation of T Cell Immunoassay for immuno-oncology
FY 2021-22 · 2022-01-03
Summary
This project will involve the development and validation of an assay to detect tumor associated antigen (TAA) and tumor neoantigen (TN)-specific cancer fighting T cells in a small sample of peripheral blood to as a diagnostic assay to 1) identify candidates for immune checkpoint inhibitor (ICI) treatment and 2) assess the ability to mount an anti-tumor immune response after immunotherapy or chemotherapy.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
705017879
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2022-08-31
Agreement Number
983842
Agreement Start Date
2022-01-03
Agreement Title
Development and validation of T Cell Immunoassay for immuno-oncology
Agreement Title (French)
Développement et validation de l'immuno-essai des cellules T pour l'immuno-oncologie
Agreement Type
Contribution
Agreement Value
$35,200.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will involve the development and validation of an assay to detect tumor associated antigen (TAA) and tumor neoantigen (TN)-specific cancer fighting T cells in a small sample of peripheral blood to as a diagnostic assay to 1) identify candidates for immune checkpoint inhibitor (ICI) treatment and 2) assess the ability to mount an anti-tumor immune response after immunotherapy or chemotherapy.
Description (French)
Ce projet comprendra le développement et la validation d'un test permettant de détecter les antigènes associés aux tumeurs (AAT) et les cellules T propres aux néoantigènes tumoraux (NT) qui combattent le cancer dans un petit échantillon de sang périphérique. Il s'agira d'un test de diagnostic permettant 1) de déterminer les candidats à un traitement par inhibiteur de point de contrôle immunitaire et 2) d'évaluer la capacité à organiser une réponse immunitaire antitumorale après une immunothérapie ou une chimiothérapie.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Granville
Federal Riding (French)
Vancouver Granville
Federal Riding Number
59036
NAICS Code
6215
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
705017879
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Immunity Diagnostics Inc
Recipient Postal Code
V5Z 3Y1
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2021-2022-Q4-983842
